Snapshot · FTSE 250 · generated 2026-10-13 03:44 UTC

BPCR.L — BioPharma Credit Ord

N/A · Quality 50/100

BPCR.L - BioPharma Credit Ord
Data generated 2026-10-13 03:44 UTC (nightly scan, universe: FTSE 250).
Price: 0.97 USD
Implied growth (reverse DCF): -1.0% (model assumes +5.8%)
Valuation: N/A
Value Score: 33.1
Quality: 50/100
N/A - Quality 50/100
Red flags: Intrinsic value rests on a default/estimated input.
Source: StocksDeepDive - https://stocksdeepdive.com/s/BPCR.L
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

0.97

Intrinsic value

Margin of safety

Implied growth (reverse DCF)

-1.0%

model assumes +5.8%

Value Score

33.1

Quality

Psychology

-2.5

Discovery

8.5

price/volume attention only

Moat score

n/a

erosion: none

Value Score: top 45% of FTSE 250 · Quality: bottom 27%

Dividend: 0.0845/share (TTM) · yield 8.7%

Open the interactive Deep Dive for BPCR.L →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BPCR.L - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is BioPharma Credit Ord's Value Score?

BioPharma Credit Ord's Value Score is 33.1 as of 2026-10-13 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.

Does BPCR.L pay a dividend?

Yes - BPCR.L's trailing twelve-month dividend is 0.0845/share, a yield of 8.7% at the current price (as of 2026-10-13).